Whether you're a seasoned data maverick or a curious newcomer, this challenge is your ticket to experiencing the power of spatial data analysis. The Challenge is LIVE NOW and remains open until 30th November 2023. During this period you can participate at your pace. Depending on your familiarity with Conda and Jupyter, you may need 3 to 6 hours in total to complete all the tasks. Embrace this chance to make your mark in spatial transcriptomics, and win epic prizes such as STOmics Cloud subscriptions valued up to $9,500, Fitbit Smart Watches, ergonomic wireless keyboard & mouse sets, and STOmics Rubik's Cubes, to keep your mind and boy fit! Seize this opportunity to wield the power of Stereo-seq, the most accessible spatial platform brought to you by MGI and STOmics.
Registration is open. Sign up now and secure your spot!🧬🏆⏰
Congratulations to the parent company BGI Group on reaching this incredible milestone, celebrating 24 years of unwavering dedication, innovation, and continued growth! Omics for all!
Dr. Ankur Sharma, Head of Onco-Fetal Ecosystem Laboratory at the Harry Perkins Institute of Medical Research, has partnered with BGI Group to use Stereo-seq to reveal new ways of combating liver cancer.
BGI Australia will look to expand its testing scope and demonstrate its capabilities in clinical solutions, as well as seek partnerships in technology transfer to make genomic testing more accessible to the community.
Brisbane, 20 October 2022 – BGI Australia’s lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing in Australia. The state-of-the-art facility has been empowering Australian scientists in their innovative research since 2017 and is now providing clinical services for the wider community. The NATA accreditation adopts the internationally-recognised ISO15189 and meets the accreditation standards for pathology laboratories set by the National Pathology Accreditation Advisory Council. Dr. Bicheng Yang, Director of BGI Australia said “We will continue to improve and increase the accessibility of clinical sequencing to clinical laboratories, research institutes and hospitals.”
Salamander brains share some, but not all, structures with the mammalian brain. They also have greater capacity to regenerate in response to damage. Three groups now come together with single-cell transcriptomics analyses that set the salamander brain in evolutionary context (see the Perspective by Faltine-Gonzalez and Kebschull). By comparing salamander brains with those of lizard, turtle, and mouse, Woych et al. track the evolutionary innovations that gave rise to the mammalian six-layered neocortex, which salamanders do not have. Lust et al. take a close look at why the axolotl brain is so much more capable of regeneration than is the mammalian brain. Finally, Wei et al. compare the developmental and regenerative processes in the axolotl brain. Read the full paper at the button below.
Watch the interview with Prof. Robert Henry, Queensland Alliance for Agriculture and Food Innovation, the University of Queensland, on his research on macadamia and beyond to benefit the future of agriculture
BGI announces that its 2019-nCoV Ag Test has recently been included in the Australian Register of Therapeutic Goods (ARTG).
The test kit is designed for detecting SARS CoV-2 nucleocapsid protein antigen for individuals suspected to have contracted COVID-19.
BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.
Check in on the latest news at BGI Australia.
Keep an eye out here for our promotions and grants. Be notified when applications open.
Join us at upcoming tradeshows, conferences and other events. We are in the process of confirming our plans for 2022. Visit us back soon.
Register to attend/view our upcoming and past free Webinars, brought to you by BGI Genomics & MGI.
Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources,
BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.
Check out our latest range of MGI sequencing platforms and diagnostic devices.
We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.
We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.
We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.
L6, CBCRC Building, QIMR Medical Rsearch Institute, 300 Herston Road, Herston, Queensland 4006, Australia
Monday — Friday: 9AM — 5PM
Saturday — Sunday: Closed